home / stock / fbt / fbt news


FBT News and Press, First Trust Amex Biotech Index Fund From 08/16/22

Stock Information

Company Name: First Trust Amex Biotech Index Fund
Stock Symbol: FBT
Market: NYSE

Menu

FBT FBT Quote FBT Short FBT News FBT Articles FBT Message Board
Get FBT Alerts

News, Short Squeeze, Breakout and More Instantly...

FBT - ImmunoGen: Mirvetuximab Decision Expected For November

ImmunoGen announced that it will receive the FDA decision for mirvetuximab on November 28th. The deal with Oxford BioTechnologies will support further growth. ImmunoGen remains robust from a financial point of view. Two weeks ago, the leading biotech company ImmunoGen, I...

FBT - Why Health Care Stocks May Be Poised To Beat The Broader Market

Why health care stocks may outperform the broader market in the long run. Is now the time to consider health care stocks? Why health care is still a good way for investors to play defense. Greg Bonnell: Many health care stocks are down from the highs put in e...

FBT - Selecta: ImmTOR Could Change Autoimmune Disorder Treatment Landscape

Results for both studies from the DISSOLVE phase 3 program, using SEL-212 for the treatment of patients with chronic refractory gout, are expected in Q1 of 2023. Potential to restore immune tolerance and target underlying cause of patients with primary biliary cirrhosis with use of Im...

FBT - Sarepta: Advancement In DMD Space With SRP-9001 And Licensed MyoAAV

BLA filing of SRP-9001 for the treatment of patients with DMD is expected in fall of 2022; If filing and review go well then FDA Accelerated approval possible mid-2023. The global market opportunity for Duchenne Muscular Dystrophy is expected to reach $4.11 billion by 2023. Sarept...

FBT - Global X House Views: July 2022

Elevated inflation, slowing global economic growth expectations, and reduced central bank liquidity remain the key economic considerations. The policy interest rate divergence between the U.S. and Europe is likely to increase amid heightened recession risk in Europe. We expect mar...

FBT - Sustainable Challenges Sharpen Equity Investing Opportunities

The investment landscape has been much more difficult for most sustainable portfolios since the fourth quarter of last year. One thing that we know is that the sustainability challenges that these stocks are connected to haven’t gone away. If anything, the economic challeng...

FBT - Genomic & Biotech ETFs pop, including Cathie Wood's ARKG

Biotechnology and genomics-based exchange traded funds like the Genomics & Biotechnology ETF ( NASDAQ: GNOM ) and ARK Genomics ETF ( BATS: ARKG ) jumped higher on Wednesday’s session off the back of healthcare tech stocks. GNOM +5.7% and ARKG +5% c...

FBT - Reimagining 'Scoping' To Save Lives

A convergence of technologies is set to revolutionize how physicians examine the body for signs of cancer. there is every reason to expect that future evolution of robotic endoluminal procedures could include the ability during the procedure to treat the cancer, either via ablation or...

FBT - SIGA Technologies: Unjustified Selloff, Loading The Boat, Best Monkeypox Play

After the FDA provided an update on the agency's response to the monkeypox outbreak on July 29th, investors misunderstood the FDA's statements, and the stock sold off 33% and shortly reverted. SIGA's monkeypox treatment TPOXX is already approved in the U.S., EU, and Canada for smallpo...

FBT - Prime Health

Per capita U.S. healthcare spending went from $2,968 in 1980 to $12,531 in 2020 (both in 2020 dollars), more than a threefold increase. Amazon announced its plans to acquire primary healthcare company One Medical for $3.9 billion. I believe this deal represents the catalyst for a sign...

Previous 10 Next 10